300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Retail
Oil and Gas
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Social Network
Blockchain
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Poland
Oman
Puerto Rico
Cameroon
Guernsey
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Botswana
Moldova
Seychelles
Paraguay
Japan
Ireland
Canada
United Kingdom
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
San Marino
Slovenia
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Ozlem Tumer Eke, Angel Investor

Ozlem Tumer Eke

Angel Investor

Istanbul, Turkey

Ozlem Tumer Eke is an angel Investor.

Total investments:
8
Last investment:
Lead investor:
13%

Last updated:

Industries Ozlem Tumer Eke invests in

BiotechnologyAgTechBeautySoftwareWellness

Stages Ozlem Tumer Eke invests in

SeedPre-SeedGrant

Countries Ozlem Tumer Eke invests in

Turkey

Round sizes

Seed $850k–$2MPre-Seed $495k–$1M

Round size

Seed
$850k–$2M
Pre-Seed
$495k–$1M

Investment Focus

Industry

  • Biotechnology 3 (38%)
  • AgTech 1 (13%)
  • Beauty 1 (13%)
  • Software 1 (13%)
  • Wellness 1 (13%)
See all 12 industries →

Stage

  • Seed 4 (50%)
  • Pre-Seed 2 (25%)
  • Grant 1 (13%)

Investments

CompanyDescriptionRoundLinks
reprai reprai
reprai is the pharma-native AI built to automate and optimize the operations of pharmaceutical companies. The company is dedicated to making pharmaceutical operations smarter, faster, and more efficient than ever before. $1M / Pre-Seed / Sep 01, 2025
text2test text2test
Text2Test is an AI-based approach that allows for the creation of executable, maintainable, and self-healing end-to-end tests using unrestricted plain language descriptions without a need for technical expertise. $495K / Pre-Seed / Nov 29, 2024
F4e F4e
F4e is an employee performance management platform that helps to manage and improve employee performance by using AI. $1M / Seed / Aug 17, 2024
Cellestetix Cellestetix
Cellestetix is a biotech company that specializes in developing and commercializing plant-based exosome formulas for regenerating skin, hair, and wellness. $2M / Seed / Aug 16, 2024
PhiTech Bioinformatics PhiTech Bioinformatics
PhiTech Bioinformatics translates genome-wide molecular data, Transcriptomics, Epigenomics, Microbiomics into biotechnology solutions. $1.1M / Seed / Mar 08, 2024
Nanomik Biotechnology Nanomik Biotechnology
Nanomik Biotechnology produces next generation biofungicides that increase the shelf life of fresh fruits and vegetables. Antimicrobial raw materials produced by microorganisms isolated from nature and active molecules obtained from plants are placed in micro-sized biopolymer capsules and applied to fruits. These completely natural microcapsulesadhere to the fruit and open within 24-48 hours and provide protection on the surface. While the biopolymer material forms an edible layer on the fruit, the ingredients in it prevent the growth of molds present in the medium. Unlike chemical fungicides, our products do not cause any harm to human and environment. $878K / Grant / Dec 21, 2022
Nanomik Biotechnology Nanomik Biotechnology
Nanomik Biotechnology produces next generation biofungicides that increase the shelf life of fresh fruits and vegetables. Antimicrobial raw materials produced by microorganisms isolated from nature and active molecules obtained from plants are placed in micro-sized biopolymer capsules and applied to fruits. These completely natural microcapsulesadhere to the fruit and open within 24-48 hours and provide protection on the surface. While the biopolymer material forms an edible layer on the fruit, the ingredients in it prevent the growth of molds present in the medium. Unlike chemical fungicides, our products do not cause any harm to human and environment. $850K / Seed / Dec 20, 2022
Nanomik Biotechnology Nanomik Biotechnology
Nanomik Biotechnology produces next generation biofungicides that increase the shelf life of fresh fruits and vegetables. Antimicrobial raw materials produced by microorganisms isolated from nature and active molecules obtained from plants are placed in micro-sized biopolymer capsules and applied to fruits. These completely natural microcapsulesadhere to the fruit and open within 24-48 hours and provide protection on the surface. While the biopolymer material forms an edible layer on the fruit, the ingredients in it prevent the growth of molds present in the medium. Unlike chemical fungicides, our products do not cause any harm to human and environment. $850K / Seed / Dec 20, 2022

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Retail
Oil and Gas
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Social Network
Blockchain
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Poland
Oman
Puerto Rico
Cameroon
Guernsey
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Botswana
Moldova
Seychelles
Paraguay
Japan
Ireland
Canada
United Kingdom
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
San Marino
Slovenia
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Ozlem Tumer Eke invest in?

Ozlem Tumer Eke invests primarily in Biotechnology, AgTech and Beauty startups, most often at Seed and Pre-Seed stage. Most of the 8 investments tracked by Shizune back companies in Turkey. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Ozlem Tumer Eke's check size?

Ozlem Tumer Eke typically joins rounds of $850k–$2M at Seed and $495k–$1M at Pre-Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Ozlem Tumer Eke participates in.

When did Ozlem Tumer Eke last invest?

The most recent investment recorded for Ozlem Tumer Eke closed in Sep 2025. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Ozlem Tumer Eke Ozlem Tumer Eke Find email